These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 16955243)
1. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243 [TBL] [Abstract][Full Text] [Related]
2. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial]. Kłos K; Kruszewski J; Kruszewski R; Sułek K Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. Frossard N; Strolin-Benedetti M; Purohit A; Pauli G Br J Clin Pharmacol; 2008 Feb; 65(2):172-9. PubMed ID: 17953719 [TBL] [Abstract][Full Text] [Related]
4. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial]. Kruszewski J; Kłos K; Sułek K Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837 [TBL] [Abstract][Full Text] [Related]
5. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours. Purohit A; Melac M; Pauli G; Frossard N Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765 [TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Grant JA; Riethuisen JM; Moulaert B; DeVos C Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. Denham KJ; Boutsiouki P; Clough GF; Church MK Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518 [TBL] [Abstract][Full Text] [Related]
8. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Passalacqua G; Canonica GW Clin Ther; 2005 Jul; 27(7):979-92. PubMed ID: 16154477 [TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. Purohit A; Melac M; Pauli G; Frossard N Br J Clin Pharmacol; 2003 Oct; 56(4):388-94. PubMed ID: 12968983 [TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers. Bulca S; Bayramgürler D; Odyakmaz Demirsoy E; Yavuz M; Sikar Aktürk A; Bilen N; Kıran R J Dermatolog Treat; 2013 Dec; 24(6):473-6. PubMed ID: 23441762 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours. Passalacqua G; Guerra L; Compalati E; Massacane P; Rogkakou A; Zanella C; Baena-Cagnani R; Canonica GW Int Arch Allergy Immunol; 2004 Oct; 135(2):143-7. PubMed ID: 15345913 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antihistamine effects of olopatadine and levocetirizine during a 24-h period: a double-blind, randomized, cross-over, placebo-controlled comparison in skin responses induced by histamine iontophoresis. Takeo T; Kasugai C; Tanaka R; Ando T; Ogawa A; Akita Y; Watanabe D J Dermatol; 2013 Dec; 40(12):987-92. PubMed ID: 24303975 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare. Meltzer EO; Gillman SA Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761 [TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of levocetirizine, desloratidine and fexofenadine by histamine wheal suppression test. Dhanya NB; Thasleem Z; Rai R; Srinivas CR Indian J Dermatol Venereol Leprol; 2008; 74(4):361-3. PubMed ID: 18797058 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Clough GF; Boutsiouki P; Church MK Allergy; 2001 Oct; 56(10):985-8. PubMed ID: 11576078 [TBL] [Abstract][Full Text] [Related]
16. Levocetirizine better protects than desloratadine in a nasal provocation with allergen. Deruaz C; Leimgruber A; Berney M; Pradervand E; Spertini F J Allergy Clin Immunol; 2004 Apr; 113(4):669-76. PubMed ID: 15100671 [TBL] [Abstract][Full Text] [Related]
17. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988 [TBL] [Abstract][Full Text] [Related]
19. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302 [TBL] [Abstract][Full Text] [Related]
20. Facial thermography is a sensitive tool to determine antihistaminic activity: comparison of levocetirizine and fexofenadine. Larbig M; Burtin B; Martin L; Stamm H; Luettig B; Hohlfeld JM; Krug N Br J Clin Pharmacol; 2006 Aug; 62(2):158-64. PubMed ID: 16842390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]